| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: CTMI |
| Security Type |
Common Stock |
| Lead Underwriter |
Credit Suisse First Boston |
| Days In Registration |
- |
| Date Filed |
- |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Manufacture positron emission tomography (PET) equipment and radiopharmaceuticals |
| Revenue |
$247.3M |
| Net Income |
-$5.6M |
| Shares Outstanding (post-offering) |
40.82M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
10.72M |
| Secondary Shares Filed | 0.72M |
| · As a Percent |
6.7 |
| Primary Shares Filed |
10.0M |
| · As a Percent |
93.3 |
| Overallotment Shares Filed |
1608.0K |
| File Amount |
$182.24M |
| File Price Range |
$18.00 - $16.00 |
| File Mid Price |
$17.00 |
Current Filing Information
(Amended 14-Jun-2002) |
|
US |
|
Shares Filed |
10.72M |
| Secondary Shares Filed |
0.72M |
| · As a Percent |
6.7 |
| Primary Shares Filed |
10.0M |
| · As a Percent |
93.3 |
| Overallotment Shares Filed |
- |
| File Amount |
$182.24M |
| · % Change from Original |
0.0 |
| File Price Range |
$18.00 - $16.00 |
| File Mid Price |
$17.00 |
|
